@article{7db024deaa034f98a215ee3abcbe152b,
title = "Corpus callosum white matter diffusivity reflects cumulative neurological comorbidity in tuberous sclerosis complex",
abstract = "Introduction: Neurological manifestations in Tuberous Sclerosis Complex (TSC) are highly variable. Diffusion tensor imaging (DTI) may reflect the neurological disease burden. We analyzed the association of autism spectrum disorder (ASD), intellectual disability (ID) and epilepsy with callosal DTI metrics in subjects with and without TSC. Methods: 186 children underwent 3T MRI DTI: 51 with TSC (19 with concurrent ASD), 46 with non-syndromic ASD and 89 healthy controls (HC). Subgroups were based on presence of TSC, ASD, ID, and epilepsy. Density-weighted DTI metrics obtained from tractography of the corpus callosum were fitted using a 2-parameter growth model. We estimated distributions using bootstrapping and calculated half-life and asymptote of the fitted curves. Results: TSC was associated with a lower callosal fractional anisotropy (FA) than ASD, and ASD with a lower FA than HC. ID, epilepsy and ASD diagnosis were each associated with lower FA values, demonstrating additive effects. In TSC, the largest change in FA was related to a comorbid diagnosis of ASD. Mean diffusivity (MD) showed an inverse relationship to FA. Some subgroups were too small for reliable data fitting. Conclusions: Using a cross-disorder approach, this study demonstrates cumulative abnormality of callosal white matter diffusion with increasing neurological comorbidity.",
keywords = "autism spectrum disorder, diffusion tensor imaging, epilepsy, intellectual disability, tuberous sclerosis complex",
author = "Baumer, {Fiona M.} and Peters, {Jurriaan M.} and Sean Clancy and Prohl, {Anna K.} and Prabhu, {Sanjay P.} and Benoit Scherrer and Jansen, {Floor E.} and Braun, {Kees P.J.} and Mustafa Sahin and Aymeric Stamm and Warfield, {Simon K.}",
note = "Funding Information: F.M.B. is supported by a KL2 Mentored Career Development Award of the Stanford Clinical and Translational Science Award to Spectrum (NIH KL2 TR 001083) and (UL1 TR 001085). J.M.P., S.C., B.S., M.S., and S.W. are supported by NIH R01 NS079788 and U01 NS082320 grants. A. Prohl is supported by Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH award UL1 TR001102). S. Prabhu is supported by the Department of Defense W81XWH-11-1-0365 and NIH U01 NS082320 grants. F.E.J. is supported by the Framework Program FP7/2007-2013 under the project acronym EPISTOP (grant agreement no. 602 391). K.P.J.B. reports no disclosures relevant to the manuscript. M.S. is additionally supported by an NIH U54 HD090255 grant and the Boston Children{\textquoteright}s Hospital Translational Research Program. The Developmental Synaptopathies Consortium (U54 NS092090) is part of the NCATS Rare Diseases Clinical Research Network (RDCRN). RDCRN is an initiative of the Office of Rare Diseases Research (ORDR), NCATS, funded through collaboration between NCATS, NIMH, NINDS, and NICHD. A.S. is supported by an NIH R01 EB013248 grant. Publisher Copyright: {\textcopyright} The Author 2017. Published by Oxford University Press.",
year = "2018",
month = oct,
day = "1",
doi = "10.1093/cercor/bhx247",
language = "English",
volume = "28",
pages = "3665--3672",
journal = "Cerebral Cortex",
issn = "1047-3211",
publisher = "Oxford University Press",
number = "10",
}